Trump Action Archive

Supporting reports

• FDA announces temporary guidance for compounding starter parenteral nutrition products for neonates — The Food and Drug Administration published guidance establishing temporary enforcement policies for compounding certain starter parenteral nutrition drug products for neonates. The guidance applies to both pharmacy compounders under Section 503A and outsourcing facilities under Section 503B of the Federal Food, Drug, and Cosmetic Act. FDA implemented the guidance immediately without prior public comment to ensure continued patient access to essential neonatal nutrition products following the expected market exit of a predominant supplier. The guidance remains subject to subsequent public comment.
• FDA determines regulatory review period for ANDEMBRY patent term extension — The Food and Drug Administration determined the regulatory review period for ANDEMBRY (garadacimab-gxii), a human biological product for hereditary angioedema prophylaxis, as 2,528 days (1,916 testing phase, 612 approval phase). The determination, made pursuant to patent term restoration law, establishes the maximum potential patent extension length. The testing phase began July 14, 2018; the complete application was submitted October 13, 2023; approval occurred June 16, 2025. Interested parties may petition FDA by March 8, 2027, to challenge the dates or contest due diligence.
• FDA determines regulatory review period for ANKTIVA patent extension — The Food and Drug Administration has determined that the regulatory review period for ANKTIVA (nogapendekin alfa inbakicept-pmln), a human biological product approved for treating BCG-unresponsive nonmuscle invasive bladder cancer, is 3,922 days (3,222 testing phase, 700 approval phase). The determination spans from July 26, 2013 (investigational exemption effective date) through April 22, 2024 (approval date). This establishes the maximum potential patent extension length; the applicant seeks between 795 and 1,827 days of actual extension across five patents. Comments on date accuracy are due by November 9, 2026; petitions regarding applicant diligence are due by March 8, 2027.
• FDA determines regulatory review period for ANZUPGO patent extension at 3,532 days — The Food and Drug Administration determined the regulatory review period for ANZUPGO (delgocitinib), a topical treatment for chronic hand eczema, to be 3,532 days (3,167 testing phase, 365 approval phase), spanning from November 20, 2015 (investigational exemption effective date) through July 23, 2025 (NDA approval). The determination establishes the maximum potential patent extension length; the applicant seeks 1,827 days of actual extension. Comments on date accuracy are due by November 9, 2026; petitions regarding due diligence may be filed by March 8, 2027.
• GSA submits Accessibility Conformance Report Repository information collection to OMB for review — The General Services Administration's Office of Governmentwide Policy submitted a new information collection requirement to the Office of Management and Budget for review and approval regarding a centralized Accessibility Conformance Report (ACR) Repository. The repository will allow federal agencies and the public to access vendor-submitted accessibility reports for information and communication technology products, supporting Section 508 compliance and federal procurement decisions. A 60-day public comment period closed with eight comments received; GSA responded to concerns about administrative burden, public access, sustainability, and standardization.
• EPA submits non-substantive changes to three information collection requests for grant performance reporting to OMB for review — The Environmental Protection Agency published a notice soliciting public comment on proposed non-substantive revisions to three information collection requests (ICRs) governing performance reporting by EPA grant recipients. The changes align ICR forms with Executive Orders issued by the current Administration regarding naming conventions, merit-based opportunity, and state/local preparedness. The ICRs cover General Performance Reporting for Assistance Programs (ICR 2802.01), Promoting Readiness and Enhancing Proficiency to Advance Reporting and Data (ICR 2804.01), and the National Estuary Program (ICR 1500.11). EPA stated the changes are non-substantive and impose no additional burden on respondents. A 30-day public comment period ends October 9, 2026.
• FDA announces Vaccines and Related Biological Products Advisory Committee meeting on 2027 Southern Hemisphere influenza vaccine strain selection — The Food and Drug Administration published notice of a public advisory committee meeting scheduled for October 1, 2026, to discuss and recommend influenza virus vaccine strains for the 2027 Southern Hemisphere influenza season. The meeting will be held online via teleconference. FDA established a public docket (FDA-2026-N-10232) accepting comments through September 29, 2026. Background materials will be posted two business days before the meeting. Interested persons may submit written comments or request time for oral presentations by September 22, 2026.
• FDA Proposes Reinstatement of Information Collection for Human Cells, Tissues, and Cellular and Tissue-Based Products — The Food and Drug Administration published a notice soliciting public comment on the proposed reinstatement of an existing information collection under the Paperwork Reduction Act. The collection supports regulatory requirements governing human cells, tissues, and cellular and tissue-based products (HCT/Ps) regulated solely under section 361 of the Public Health Service Act. The notice invites comments on necessity, burden accuracy, quality enhancement, and burden minimization. The comment period closes November 9, 2026.
• FDA solicits public comment on proposed information collection for Pregnancy Exposure Registry Enrollment Project survey — The Food and Drug Administration announced a proposed collection of information under the Paperwork Reduction Act, seeking public comment on a voluntary survey of healthcare providers regarding barriers to patient enrollment in pregnancy exposure registries. The FDA will survey approximately 400 healthcare providers (obstetrician/gynecologists, family medicine physicians, nurse-midwives, physician assistants, specialists, and pharmacists) via internet-administered questionnaire to understand their knowledge, attitudes, and perceived obstacles to recruiting pregnant patients into drug safety registries. Results will inform regulatory guidance on registry protocol design and pregnancy labeling. The comment period closes November 9, 2026.
• EPA solicits public comment on renewal information collection for PBT chemical regulations under TSCA Section 6(h) — The Environmental Protection Agency announced a proposed renewal of an Information Collection Request (ICR No. 2599.04, OMB Control No. 2070-0213) governing reporting and compliance activities for five persistent, bioaccumulative, and toxic chemicals: decabromodiphenyl ether, phenol isopropylated phosphate, 2,4,6-tris(tert-butyl)phenol, pentachlorothiophenol, and hexachlorobutadiene. The renewal consolidates this ICR with a separate 2024 final-rule ICR, increasing total estimated annual burden to 42,309 hours across approximately 26,829 respondents. Public comment period closes November 9, 2026.
• EPA solicits public comment on renewal of information collection request for TSCA user fees — The Environmental Protection Agency announced a proposed renewal of an existing Information Collection Request (ICR No. 2569.07, OMB Control No. 2070-0208) governing user fees for administering the Toxic Substances Control Act. The ICR addresses fee collection from manufacturers and importers of chemical substances under TSCA sections 4, 5, and 6. The renewal reflects a decrease of 269 hours in estimated respondent burden compared to the prior approval. EPA solicits public comment through November 9, 2026, before submitting the final ICR to OMB for review and approval.
• FCC Invites Public Comment on Information Collection for Cable Service Rate Certification Petitions — The Federal Communications Commission published a notice requesting public comments on an information collection under the Paperwork Reduction Act. The collection concerns 47 CFR 76.916, which governs petitions filed by franchising authorities seeking recertification to regulate basic cable service rates after prior certification denial or revocation. The FCC estimates 2 respondents submitting 3 responses annually, with 10 hours per response and 30 total annual burden hours. Comments are due by November 9, 2026.
• FCC Requests Public Comments on Information Collection for Universal Service Auction Eligibility and Bidding Communications — The Federal Communications Commission issued a notice requesting public comments on an information collection under the Paperwork Reduction Act. The collection (OMB Control Number 3060-1166) pertains to FCC rules sections 1.21001 and 1.21002, which govern eligibility determinations and prohibited communications during competitive bidding for Universal Service Fund support. The FCC seeks feedback on necessity, burden estimates, and ways to minimize compliance costs for respondents, particularly small businesses. Comments are due by November 9, 2026.
• FCC requests public comments on information collection requirements for satellite and earth station licensing — The Federal Communications Commission issued a notice requesting public comments on revised information collection requirements under OMB Control No. 3060-0678, governing licensing and spectrum usage by commercial earth stations and space stations under Part 25 of FCC rules. The revision reflects two recent FCC orders: a Second Report and Order (FCC 25-48, August 8, 2025) streamlining satellite and earth station application processing, and a Report and Order (FCC 26-26, May 1, 2026) modernizing spectrum-sharing criteria for satellite broadband. The collection affects approximately 4,171 respondents with an estimated annual burden of 37,129 hours and annual cost of $7,159,040. Comments are due by November 9, 2026.
• FDA announces priority review voucher fee rate for fiscal year 2027 — The Food and Drug Administration published a notice establishing the fiscal year 2027 fee rate for using priority review vouchers at $1,798,596. This fee applies to applications for tropical disease, rare pediatric disease, or material threat medical countermeasure products submitted with a priority review voucher, in addition to standard Prescription Drug User Fee Act fees. The rate is effective October 1, 2026, through September 30, 2027, and was calculated based on the difference between average costs of priority and standard drug application reviews in fiscal year 2025, adjusted for cost increases.
• GSA releases FY 2027 CONUS per diem reimbursement rates for federal employee travel — The General Services Administration published Federal Travel Regulation Bulletin FTR 27-01, establishing maximum per diem reimbursement rates for federal employees traveling within the Continental United States during fiscal year 2027. The standard lodging rate increases by $3 to $113 per night, following a rate freeze in FY 2026. Meals and incidental expenses (M&IE) reimbursement rates remain at $68–$92, with the standard M&IE rate at $68. The rates apply to travel performed October 1, 2026, through September 30, 2027. Agencies may request GSA review of rates for specific locations if insufficient to meet necessary expenses.
• EPA solicits public comment on NASA's emergency exemption application for ortho-phthalaldehyde use on International Space Station — The Environmental Protection Agency announced receipt of a specific exemption request from NASA under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) section 18 to use ortho-phthalaldehyde (OPA) as a biocide in the International Space Station's internal active thermal control system coolant. OPA, an unregistered pesticide, would control aerobic and microaerophilic bacteria in the aqueous coolant at concentrations up to 350 mg/liter. NASA asserts OPA is the most effective biocide meeting safety and material-compatibility criteria, with no adequate alternative long-term solution available. The EPA is soliciting 15 days of public comment before deciding whether to grant the exemption, which NASA expects to continue through 2030.
• EPA solicits public comment on renewal of information collection for soil and non-soil fumigant risk mitigation measures — The Environmental Protection Agency announced a proposed renewal of an existing Information Collection Request (ICR No. 2451.04, OMB Control No. 2070-0197) governing fumigant risk mitigation activities. The ICR documents paperwork requirements for fumigant users, registrants, and states implementing risk mitigation measures under the Federal Insecticide, Fungicide, and Rodenticide Act. The renewal reflects an increase of 333,720 burden hours and adds Ethylene Oxide-using facilities to the scope. Public comment period closes November 10, 2026.
• FDA finalizes removal of PABA and trolamine salicylate from OTC sunscreen monograph — The Food and Drug Administration issued final administrative order OTC000008-1, removing aminobenzoic acid (PABA) and trolamine salicylate as permitted active ingredients in over-the-counter sunscreen drug products under OTC Monograph M020. FDA determined these ingredients are not generally recognized as safe and effective (GRASE) because available safety data shows risks outweigh benefits. The final order was announced on the FDA website and published in the Federal Register on September 11, 2026, following a proposed order issued in September 2021 with an extended comment period.
• FDA solicits public comment on medical device tracking information collection requirements — The Food and Drug Administration published a notice requesting public comment on the proposed extension of an existing information collection under the Paperwork Reduction Act. The collection pertains to tracking requirements for class II and III medical devices that meet specified criteria—including those likely to cause serious adverse health consequences, implanted devices, or life-sustaining devices used outside facilities. The comment period closes November 10, 2026. FDA estimates 22,000 potential respondents and a total annual burden of approximately 663,000 hours across reporting, recordkeeping, and third-party disclosure activities.
• GSA rescinds and removes FMR Bulletin B-51 on executive agency property reporting — The General Services Administration rescinded and removed Federal Management Regulation (FMR) Bulletin B-51, which required annual executive agency reports on exchange/sale and personal property furnished to non-federal recipients. GSA cited the bulletin as outdated; the reporting requirement was eliminated by FMR Case 2025-05, which aligned FMR with the administration's deregulatory priorities following Executive Order 14192 (Unleashing Prosperity Through Deregulation, January 31, 2025). The action became effective immediately on September 11, 2026.
• GSA submits OMB review request for annual SAM.gov certification of higher education compliance with Executive Order 14400 on college sports — The General Services Administration submitted to the Office of Management and Budget a request to approve a new information collection requiring registered higher education institutions with $20 million or more in intercollegiate athletics revenue to certify annually their compliance with Executive Order 14400 (Urgent National Action to Save College Sports) via the System for Award Management (SAM.gov). The collection affects approximately 11,720 respondents with an estimated annual burden of 14,620 responses and 181,584.50 hours. A 30-day public comment period closes October 13, 2026.

Supporting reports

• Treasury and FinCEN eliminated beneficial ownership reporting requirement — The Treasury Department and FinCEN announced a final rule permanently eliminating the requirement for U.S. companies and individuals to report beneficial ownership information. FinCEN also announced it will delete all beneficial ownership information already collected. The beneficial ownership reporting requirement, enacted in 2020, was designed to prevent drug traffickers, Russian and Chinese kleptocrats, and international criminals from hiding money in anonymous shell companies. Former Congressman Tom Malinowski stated the move is likely illegal, as the administration is making its own rules to circumvent a law passed by Congress.
• Treasury Department repeals beneficial ownership reporting requirement — The Treasury Department officially repealed the requirement for U.S. companies and individuals to report beneficial ownership information to the Financial Crimes Enforcement Network (FinCEN), implemented under the Biden administration pursuant to the Corporate Transparency Act passed by Congress in 2020. The repeal also exempts Americans who obtained FinCEN IDs from updating or correcting information and eliminates the requirement for foreign companies to report Americans who helped them register to do business in the U.S. The original law was authored by then-Senator Marco Rubio, now Secretary of State, who had called it "the most significant anti-corruption and money laundering law in decades."

Supporting reports

• National Design Studio installs undisclosed visitor-tracking software on federal websites — The National Design Studio (NDS), a White House office led by Airbnb co-founder Joe Gebbia and staffed by Department of Government Efficiency (Doge) veterans, rebuilt sensitive federal websites for passport applications, voter registration, prescription-drug pricing, and children's savings accounts. The NDS installed commercial visitor-tracking software (PostHog) configured to evade privacy tools on four public federal websites without publishing required privacy impact assessments or system-of-records notices mandated by the Privacy Act of 1974 and E-Government Act of 2002. The NDS removed the tracking software after Guardian inquiry on 4 June; White House responded 17 June claiming compliance with legal requirements.

Supporting reports

• White House East Wing renovation costs balloon to $600 million with taxpayer funding — The Washington Post obtained internal contractor documents showing Trump's White House East Wing renovation, including a new ballroom, underground bunker, and security facilities, has grown from the $200 million Trump promised to an estimated $600 million. More than half is expected to come from taxpayers through the Secret Service, White House Military Office, and Executive Residence. Tens of millions in taxpayer funds were approved before Trump stated in March that "We have no taxpayer putting up 10 cents." The White House responded that Trump and donors are paying for the ballroom itself, ignoring other project costs.
• Trump administration approved tens of millions in taxpayer funds for White House ballroom addition — The Washington Post reported that while Trump assured the public that private donors would pay for a White House ballroom addition, the White House had already approved tens of millions of taxpayer dollars for the contractor building the addition. Internal cost estimates were significantly higher than administration officials had acknowledged in public comments or court filings. Project summaries showed the work was projected to rely heavily on taxpayer dollars from the moment it was announced.

Supporting reports

• DHS/ICE announces $38.3bn warehouse-to-detention-center conversion plan across 24 facilities — US Immigration and Customs Enforcement (ICE) and the Department of Homeland Security (DHS) disclosed plans to acquire and retrofit 24 warehouses nationwide into immigration detention centers with capacity for tens of thousands of detainees. The plan includes 16 regional processing centers (1,000–1,500 capacity each) and 8 large-scale facilities (7,000–10,000 capacity) designated as "primary locations" for deportations. DHS estimates $158m to retrofit a Merrimack, New Hampshire facility and $146m to operate it over three years. The broader $38.3bn effort is intended to support mass deportations and is funded by the One Big Beautiful Bill Act.
• ICE expands facilities across United States — ICE has quietly and aggressively expanded across the United States in recent months, buying or leasing new facilities in nearly every state, many outside the country's largest cities but concentrated in Texas. DHS asked the General Services Administration to ignore competitive bidding rules and hide lease listings citing "national security concerns."
• ICE plans $38.3 billion detention center expansion — ICE officials are planning to spend $38.3 billion to buy warehouses across the country. ICE will retrofit sixteen of them to become processing centers that can hold 1,000 to 1,500 detainees at a time before funneling them into eight megacenters that can hold up to 10,000 detainees each.

Supporting reports

• EPA proposes rollback of PFAS reporting requirements for manufacturers — The Environmental Protection Agency announced a proposed rule on November 10, 2025, weakening mandatory reporting requirements for per- and polyfluoroalkyl substances (PFAS), known as "forever chemicals" linked to cancer and immune damage. New exemptions allow companies to cease reporting if PFAS comprise less than 0.1% of a product, are byproducts, are in imported goods, or are used for research and development. The change eliminates comprehensive tracking that enabled communities to trace contamination in water supplies. EPA Administrator Lee Zeldin characterized the action as "reducing regulatory burdens."

Supporting reports

• White House OMB argues furloughed federal workers not entitled to back pay under GEFTA — The White House Office of Management and Budget issued a draft memo arguing that the Government Employee Fair Treatment Act (GEFTA) of 2019 does not automatically guarantee back pay to furloughed federal workers during the ongoing government shutdown. OMB General Counsel Mark Paoletta stated that Congress must include express appropriations language for back pay in legislation ending the shutdown. The OMB previously removed references to GEFTA from shutdown guidance. An estimated 750,000 federal workers have been furloughed as of the shutdown's seventh day.
• White House OMB memo argues federal workers not entitled to back pay — On Tuesday, the White House Office of Management and Budget released a memo contending that federal workers are not entitled to back pay during the shutdown, contradicting a 2019 law that mandates such compensation. House Speaker Mike Johnson subsequently stated at a press conference that he believes federal employees should receive back pay, citing statutory law. The memo represents an attempt to reduce pressure on Republicans to end the shutdown quickly.
• White House threatens federal workforce layoffs during shutdown — White House Press Secretary Karoline Leavitt announced that if the shutdown continued, the Trump administration would lay off federal employees, despite federal law entitling them to back pay. She also warned that a food assistance program for low-income mothers and children would exhaust its funding. Director of OMB Russ Vought had already cancelled funding for energy and transportation projects in Democratic-governed states.
• Administration announces continuation of illegal cuts during government shutdown — On October 1, 2025, as the government shutdown began, Office of Management and Budget director Russell Vought announced plans to use the shutdown to implement $26 billion in cuts to infrastructure and climate projects in Democratic-led states, as well as to lay off federal employees instead of furloughing them. This action is part of a broader strategy to impose significant cuts to government programs.
• OMB floats denial of back pay guarantee for furloughed federal workers — The Office of Management and Budget issued a memo suggesting that federal workers furloughed during a government shutdown are not guaranteed back pay when the shutdown ends, departing from the administration's own guidance issued the previous month. This reverses the 2019 law that President Trump himself signed to guarantee such pay. Administration officials told media outlets the memo is intended to give Republicans leverage in shutdown negotiations with Democrats. OMB director Russell Vought had previously threatened mass firings if Democrats refused the Republican continuing resolution.
• Trump suggested not all furloughed employees deserve back pay — Speaking to reporters alongside Canadian Prime Minister Mark Carney, Trump suggested that not all furloughed federal employees should receive back pay following the government shutdown. He noted, "It depends on who we're talking about," and added, "We're going to take care of our people. There are some people that really don't deserve to be taken care of, and we'll take care of them in a different way."
• OMB revised guidance removing back pay guarantee — Government Executive reported that the Office of Management and Budget quietly revised a guidance document last week to remove references to a law passed during Trump's first term, guaranteeing all federal workers back pay following a government shutdown.
• Trump signals furloughed federal workers may not receive back pay — During a White House event, President Trump stated that some furloughed federal workers may not receive customary back pay when the government reopens, saying "there are some people that don't deserve to be taken care of" and that back pay "depends on who we're talking about." This breaks with historical precedent and creates uncertainty for unpaid workers already under financial strain.

Supporting reports

• Trump announces $1 trillion military budget for fiscal year 2026 — On April 7, President Trump announced plans to propose a $1 trillion military budget for fiscal year 2026, representing a $107 billion increase from current spending. Trump stated during a meeting with Israeli Prime Minister Benjamin Netanyahu that the increase was necessary to strengthen U.S. military capacity. This reverses Trump's February position that military spending of nearly $1 trillion was excessive and should be reduced through arms-control negotiations with China and Russia. Secretary of Defense Pete Hegseth endorsed the proposal.
• White House warned Trump would veto tariff approval bill — The White House warned that Trump would veto a bill that would require approval from Congress to impose new tariffs.
• CNBC reported false rumor of Trump tariff pause, causing market volatility — CNBC reported a false rumor that Trump would announce a 90-day pause on tariffs after Fox host Brian Kilmeade asked White House Economic Advisor Kevin Hassett if Trump would consider such a pause. The rumor caused stock markets to rally sharply mid-morning. When the White House denied the report as "fake news," markets declined again. The false report originated from Hassett's non-committal response that "the president is gonna decide what the president is gonna decide."
• White House denied tariff pause report as fake news — The White House social media account responded to the CNBC report of a tariff pause by stating "Wrong. Fake News. Not only did Director Hassett not say this, POTUS has been clear - 'it all has to change, but especially with CHINA!!!'" The denial clarified that Trump has not agreed to any tariff pause.
• Peter Navarro stated tariffs are not a negotiation but a national emergency response — White House trade advisor Peter Navarro told Fox News that the tariffs represent "a national emergency based on a trade deficit that's gotten out of control because of cheating," explicitly rejecting the characterization of tariffs as a negotiating tactic. This statement contradicted other administration messaging suggesting tariffs were leverage for trade negotiations.
• Trump posted on Truth Social that his policies will never change — President Trump posted on Truth Social stating "MY POLICIES WILL NEVER CHANGE," signaling that tariff policy would not be reversed despite market turmoil and economic concerns. This statement contradicted earlier messaging that tariffs were negotiating tactics.
• White House issued fact sheet stating tariffs remain in effect until trade deficit threat is resolved — The White House released a fact sheet claiming that tariffs would remain in effect "until such a time as President Trump determines that the threat posed by the trade deficit and underlying nonreciprocal treatment is satisfied, resolved, or mitigated." This statement indicated tariffs were not temporary negotiating tools but permanent policy subject only to Trump's subjective determination.
• Trump announces 90-day pause on reciprocal tariffs — Hours after reciprocal tariffs took effect on April 9, 2025, Trump announced a 90-day pause on them, with the exception of China, where he increased tariffs to 125%. White House press secretary Karoline Leavitt characterized the move as part of Trump's negotiating strategy, referencing "The Art of the Deal." The pause came after stock markets had fallen sharply and amid widespread economic warnings.
• Trump announces 90-day tariff pause with modified rates, triggering market volatility and insider-trading allegations — On Wednesday, April 9, Trump announced a 90-day pause on his tariff plan, replacing his original broad tariffs with a 10% blanket rate on most countries through July, while raising China tariffs to 145% effective immediately. The announcement triggered a historic market rally Wednesday afternoon, followed by sharp sell-offs Thursday as economists warned the effective tariff rate was worse than worst-case scenarios. Democrats alleged possible insider trading and market manipulation; Republicans praised the move as strategic negotiation.
• Trump reversed course on tariffs with 90-day pause — After tanking the stock market, Trump reversed course on his "Liberation Day" tariffs. He announced a 90-day pause on a steep hike in tariffs on most countries, except for China, which he said would now face duties of 125%.
• Senators and representatives questioned insider trading related to tariff announcements. — Multiple members of Congress raised concerns about potential insider trading in the hours before Trump's tariff announcement. Senator Adam Schiff stated he would investigate whether Trump and associates tipped off friends to profit from market movements. Senator Bernie Sanders expressed skepticism that people with advance knowledge of the tariff reversal did not profit. Representative Alexandria Ocasio-Cortez called for disclosure of stock purchases made in the prior 48 hours and urged a ban on congressional insider trading. Senator Chris Murphy characterized the situation as "an insider trading scandal brewing."
• Trump's approval rating fell to 41% in new Quinnipiac poll. — A new Quinnipiac poll showed President Trump's approval rating at 41% with 53% disapproval. CNN analyst Harry Enten noted that only two presidents have had net negative approval ratings at this point in their term: Donald Trump in his first term and Donald Trump in his second term.
• White House refused to release list of 75 countries allegedly requesting tariff deals. — President Trump claimed that leaders of 75 countries had called "kissing my ass" to request trade deals, prompting him to lift most tariffs. When NBC News requested the list of these 75 countries, the White House refused to release it. The refusal raised questions about the veracity of Trump's claim and the basis for the tariff reversal.
• 30-year mortgage rates surge to 7.1% — The average mortgage rate on 30-year fixed-rate mortgages surged 1.3 basis points to 7.1% on this date. Matthew Graham, COO of Mortgage News Daily, characterized the week as the worst for bond markets in terms of 10-year yield jumps for anyone whose career began after 1981, indicating severe market volatility tied to administration policy.